Keywords: mgi, file, nausea, drug, after, fda, meeting

MGI to file nausea drug after FDA meeting

Article | 13 May 2002

Print This

The USA's MGI Pharma and partner Helsinn Healthcare of Switzerlandhave announced plans to file for approval of palonosetron, their new, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in